A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques.

類似資料

• Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice.
  著者:: Hanke, T, 等
  出版事項: (2005)
• Induction of long-lasting multi-specific CD8+ T cells by a four-component DNA-MVA/HIVA-RENTA candidate HIV-1 vaccine in rhesus macaques.
  著者:: Im, E, 等
  出版事項: (2006)
• Development of a DNA-MVA/HIVA vaccine for Kenya.
  著者:: Hanke, T, 等
  出版事項: (2002)
• Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models
  著者:: Lynette Siv Chea, 等
  出版事項: (2017-10-01)
• Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya.
  著者:: Hanke, T, 等
  出版事項: (2002)